panda448https://investorshangout.com/profile/view?id=65632en-usThu, 22 Oct 2026 06:56:20 GMTCopyright InvestorsHangout.companda448: Oncotelic Announces Release of Pet2DAO Tokenshttps://investorshangout.com/post/view?id=6557364https://investorshangout.com/post/view?id=6557364Thu, 06 Apr 2023 00:42:29 GMTpanda448: Oncotelic Awarded BARDA Funding for Developmenthttps://investorshangout.com/post/view?id=6486237https://investorshangout.com/post/view?id=6486237Mon, 17 Oct 2022 22:48:26 GMTpanda448: Oncotelic Announces Pipeline Presentation and IPOhttps://investorshangout.com/post/view?id=6422384https://investorshangout.com/post/view?id=6422384Wed, 15 Jun 2022 21:04:02 GMTpanda448: ONCOTELIC PROVIDES Q1 2022 FINANCIAL RESULTShttps://investorshangout.com/post/view?id=6408561https://investorshangout.com/post/view?id=6408561Mon, 23 May 2022 17:25:35 GMTpanda448: Oncotelic Appoints Fatih Uckun, M.D., Ph.D., ashttps://investorshangout.com/post/view?id=6396405https://investorshangout.com/post/view?id=6396405Wed, 04 May 2022 17:04:13 GMTpanda448: Oncotelic Appoints Seymour Fein M.D. as Chiefhttps://investorshangout.com/post/view?id=6396404https://investorshangout.com/post/view?id=6396404Wed, 04 May 2022 17:04:02 GMTpanda448: Oncotelic; Announcing Successful Joint Venturehttps://investorshangout.com/post/view?id=6377107https://investorshangout.com/post/view?id=6377107Mon, 04 Apr 2022 20:19:15 GMTpanda448: Oncotelic presentation at MedInvesthttps://investorshangout.com/post/view?id=6375599https://investorshangout.com/post/view?id=6375599Fri, 01 Apr 2022 18:21:28 GMTpanda448: Oncotelic JV Financing:https://investorshangout.com/post/view?id=6367390https://investorshangout.com/post/view?id=6367390Mon, 21 Mar 2022 19:48:37 GMTpanda448: Oncotelic; Looking at Industry Comparison for thehttps://investorshangout.com/post/view?id=6363439https://investorshangout.com/post/view?id=6363439Tue, 15 Mar 2022 23:42:49 GMTpanda448: Oncotelic; Discussing the Company's Developmenthttps://investorshangout.com/post/view?id=6363438https://investorshangout.com/post/view?id=6363438Tue, 15 Mar 2022 23:40:57 GMTpanda448: Oncotelic; Diving into the Company's Outlook forhttps://investorshangout.com/post/view?id=6363437https://investorshangout.com/post/view?id=6363437Tue, 15 Mar 2022 23:40:43 GMTpanda448: Oncotelic to Present New Studies on its TGF-ßhttps://investorshangout.com/post/view?id=6360099https://investorshangout.com/post/view?id=6360099Thu, 10 Mar 2022 19:17:44 GMTpanda448: Oncotelic; An Introduction to CFO Amit Shah & Hishttps://investorshangout.com/post/view?id=6355034https://investorshangout.com/post/view?id=6355034Wed, 02 Mar 2022 23:00:46 GMTpanda448: Oncotelic Initiates Phase 1 Trial Evaluating CA4Phttps://investorshangout.com/post/view?id=6314451https://investorshangout.com/post/view?id=6314451Wed, 05 Jan 2022 16:37:47 GMTpanda448: Oncotelic Announces that ORF8 Mutations arehttps://investorshangout.com/post/view?id=6307290https://investorshangout.com/post/view?id=6307290Wed, 22 Dec 2021 16:34:33 GMTpanda448: Oncotelic’s Dr. Anthony Maida to Present at 2ndhttps://investorshangout.com/post/view?id=6301321https://investorshangout.com/post/view?id=6301321Tue, 14 Dec 2021 17:07:13 GMTpanda448: Mesothelioma Clinical Trial to Involve Drughttps://investorshangout.com/post/view?id=6297597https://investorshangout.com/post/view?id=6297597Thu, 09 Dec 2021 00:37:25 GMTpanda448: Oncotelic 2021 Q3 Report, Litchfield reiterateshttps://investorshangout.com/post/view?id=6296626https://investorshangout.com/post/view?id=6296626Tue, 07 Dec 2021 23:44:09 GMTpanda448: Biotech Growth Stocks Set to Benefit from Risinghttps://investorshangout.com/post/view?id=6294620https://investorshangout.com/post/view?id=6294620Sat, 04 Dec 2021 00:26:03 GMTpanda448: New Oncotelic Therapeutics Inc (OTLC) Stockhttps://investorshangout.com/post/view?id=6291300https://investorshangout.com/post/view?id=6291300Mon, 29 Nov 2021 23:33:47 GMTpanda448: Oncotelic Therapeutics Inc (OTLC) stock news andhttps://investorshangout.com/post/view?id=6288349https://investorshangout.com/post/view?id=6288349Tue, 23 Nov 2021 00:55:18 GMTpanda448: Oncotelic Announces Successful Completion ofhttps://investorshangout.com/post/view?id=6284220https://investorshangout.com/post/view?id=6284220Tue, 16 Nov 2021 14:27:46 GMTpanda448: Another TGF-beta acquisition- bode well forhttps://investorshangout.com/post/view?id=6281201https://investorshangout.com/post/view?id=6281201Wed, 10 Nov 2021 22:47:11 GMTpanda448: $OTLC in immunotherapy space: Immunotherapyhttps://investorshangout.com/post/view?id=6278437https://investorshangout.com/post/view?id=6278437Fri, 05 Nov 2021 23:56:33 GMTpanda448: ONCOTELIC ANNOUNCES UPDATE ON THE OT-101 CLINICALhttps://investorshangout.com/post/view?id=6268575https://investorshangout.com/post/view?id=6268575Sat, 23 Oct 2021 00:15:01 GMTpanda448: ONCOTELIC ACQUIRES FAST TO MARKET LATE-STAGE DRUGhttps://investorshangout.com/post/view?id=6256134https://investorshangout.com/post/view?id=6256134Tue, 05 Oct 2021 22:19:24 GMTpanda448: OT-101 – an antisense against TGF-β2 – forhttps://investorshangout.com/post/view?id=6252159https://investorshangout.com/post/view?id=6252159Thu, 30 Sep 2021 00:17:18 GMTpanda448: ONCOTELIC TO ACQUIRE LATE-STAGE DRUG CANDIDATEhttps://investorshangout.com/post/view?id=6234367https://investorshangout.com/post/view?id=6234367Tue, 07 Sep 2021 22:46:29 GMTpanda448: PULMOHEAL™/ ARTIVEDA™ IS CLINICALLY ACTIVEhttps://investorshangout.com/post/view?id=6234366https://investorshangout.com/post/view?id=6234366Tue, 07 Sep 2021 22:45:04 GMTpanda448: ONCOTELIC AND GOLDEN MOUNTAIN PARTNERS FORMING Ahttps://investorshangout.com/post/view?id=6216336https://investorshangout.com/post/view?id=6216336Mon, 16 Aug 2021 23:04:07 GMTpanda448: Mateon Therapeutics Inc. has changed its name tohttps://investorshangout.com/post/view?id=6097171https://investorshangout.com/post/view?id=6097171Wed, 31 Mar 2021 19:24:28 GMTpanda448: Litchfield Hills upgrade price target to $4 fromhttps://investorshangout.com/post/view?id=6074630https://investorshangout.com/post/view?id=6074630Fri, 05 Mar 2021 19:04:49 GMTpanda448: MATEON THERAPEUTICS AND WINDLAS BIOTECH PUBLISHhttps://investorshangout.com/post/view?id=6072488https://investorshangout.com/post/view?id=6072488Thu, 04 Mar 2021 01:41:37 GMTpanda448: MATEON PARTNERED WITH CHOPRA FOUNDATION ONhttps://investorshangout.com/post/view?id=6055790https://investorshangout.com/post/view?id=6055790Tue, 16 Feb 2021 23:04:51 GMTpanda448: Targeting TGF-b pathway with COVID-19 Drughttps://investorshangout.com/post/view?id=6037662https://investorshangout.com/post/view?id=6037662Mon, 01 Feb 2021 23:05:26 GMTpanda448: MATEON LAUNCHING MOBILE APP, ARTIHEALTH™, FORhttps://investorshangout.com/post/view?id=6030883https://investorshangout.com/post/view?id=6030883Wed, 27 Jan 2021 01:15:48 GMTpanda448: Zacks Small Cap Research: MATN: POSITIVE INTERIMhttps://investorshangout.com/post/view?id=6019672https://investorshangout.com/post/view?id=6019672Fri, 15 Jan 2021 00:25:15 GMTpanda448: MATEON ANNOUNCES POSITIVE INTERIM RESULTS FROMhttps://investorshangout.com/post/view?id=6017912https://investorshangout.com/post/view?id=6017912Wed, 13 Jan 2021 19:35:51 GMTpanda448: Litchfield Hills Research MATN-Buy-$3 PT:https://investorshangout.com/post/view?id=6012756https://investorshangout.com/post/view?id=6012756Fri, 08 Jan 2021 18:53:46 GMTpanda448: We might need to redefine our approach to drughttps://investorshangout.com/post/view?id=6011720https://investorshangout.com/post/view?id=6011720Fri, 08 Jan 2021 00:02:27 GMTpanda448: MATEON’S GLOBAL STUDY FOR OT-101/ TGF-βhttps://investorshangout.com/post/view?id=6004089https://investorshangout.com/post/view?id=6004089Wed, 30 Dec 2020 19:48:50 GMTpanda448: Initiating coverage of MATN, Buy rating and $3https://investorshangout.com/post/view?id=5991172https://investorshangout.com/post/view?id=5991172Tue, 15 Dec 2020 18:17:00 GMTpanda448: Positive early results in treating COVID-19:https://investorshangout.com/post/view?id=5991167https://investorshangout.com/post/view?id=5991167Tue, 15 Dec 2020 18:13:54 GMT